Class II ยท Moderate risk
Naropin (ropivacaine hydrochloride Injection, USP)
Presence of Particulate Matter: Hair was found in products
National Drug Code
Is NDC 63323-0286-05 recalled?
Naropin
Yes — this exact package was recalled
1 FDA recall names the code 63323-0286-05 directly. A recall still applies to particular lot numbers — compare the lot on your package with the FDA notice below, and talk to your pharmacist before stopping a prescribed medication.
1 of these recalls is still ongoing.
- Active ingredient
- Ropivacaine Hydrochloride
- Strength
- ROPIVACAINE HYDROCHLORIDE 5 mg/mL
- Form
- Injection, Solution · Epidural, Infiltration, Perineural
- Labeler
- Fresenius Kabi USA, LLC
- Type
- Human Prescription Drug
- Product code
- 63323-0286
Recalls naming this package
Where to find this code. The NDC is printed on the pharmacy label and on the manufacturer's carton, usually as three groups of digits after “NDC”. The last group is the package size — two bottles of the same medicine can differ only in that group, and a recall may cover one but not the other.
Other recalled products from this labeler
- 63323-0162 Ketorolac Tromethamine 4
- 63323-0010 Gentamicin 2
- 63323-0184 Folic Acid 2
- 63323-0186 Sodium Chloride 2
- 63323-0269 Diprivan 2
- 63323-0365 See recall 2
Free recall alerts
Know the day your medication is recalled
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.